# Diagnostic and immunological roles of leptin gene rs7799039 polymorphism and cytokines in COVID-19, HCV, and dual infection

**Authors:** Amany A. Sakr, Amr E. Ahmed, Nabil A. Hasona, Rasha M. Abdel-Hamid, Asmaa Salman Faisal, Elsaeed E. Shaaban, Sahar Mohamed, Abbas Mohamed Abbas, Amal A. Mohamed

PMC · DOI: 10.1038/s41598-026-35418-4 · Scientific Reports · 2026-02-02

## TL;DR

This study explores how a leptin gene variant and immune markers like IL-6, TNF-α, and IFN-γ help diagnose and understand HCV, COVID-19, and co-infections.

## Contribution

The study reveals new insights into the leptin gene polymorphism rs7799039 and cytokine roles in HCV, COVID-19, and dual infections, particularly in risk stratification and immune mechanisms.

## Key findings

- TNF-α and IFN-γ are significant predictors of disease status across HCV, COVID-19, and co-infections.
- The leptin gene AA genotype is more common in COVID-19 patients, suggesting possible susceptibility.
- Cytokine levels like IL-6, TNF-α, and IFN-γ are significantly elevated in all patient groups compared to controls.

## Abstract

The identification of reliable diagnostic biomarkers is essential for improving the early detection, prognosis, and management of viral infections. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and Interferon-gamma (IFN-γ) are key cytokines involved in immune regulation and inflammatory responses, playing a pivotal role in the pathogenesis of hepatitis C virus (HCV), coronavirus disease 2019 (COVID-19), and co-infection with both viruses. This study aims to investigate the role of circulating leptin gene polymorphism (rs7799039, G > A), together with IL-6, TNF-α, and IFN-γ biomarkers, in the context of HCV, COVID-19, and dual HCV–COVID-19 infection. While previous research has examined rs7799039 in COVID-19, its contribution in co-infection remains unclear. By integrating cytokine profiling with genotypic analysis, this work provides additional insights into disease diagnosis, risk stratification, and the underlying immunopathological mechanisms of these infections. Biomarker levels were measured in plasma using enzyme-linked immunosorbent assay (ELISA). Nasopharyngeal swabs were collected for real-time polymerase chain reaction (RT-PCR) detection of COVID-19 ribonucleic acid (RNA), and blood samples were used for quantitative RT-PCR detection of HCV-RNA. Single nucleotide polymorphisms (SNP) genotyping assay for Leptin gene (rs7799039) was examined from genomic deoxyribonucleic acid (DNA) using RT-PCR. No cytokine correlations were found in HCV alone, but TNF-α and IFN-γ correlated in dual infections. IL-6, TNF-α, and IFN-γ levels were significantly elevated in all patient groups compared to controls, with mean ± SD values of IL-6: 199.2 ± 28 pg/mL (co-infected), 171 ± 31.9 pg/mL (COVID-19), and 46.8 ± 9 pg/mL (HCV); TNF-α: 64.6 ± 15.4 pg/mL, 33.5 ± 7.1 pg/mL, and 32.9 ± 6.2 pg/mL; IFN-γ: 166.2 ± 41.9 pg/mL, 116.8 ± 18.6 pg/mL, and 101 ± 14.4 pg/mL, respectively. TNF-α and IFN-γ were significant predictors of disease status across groups (OR = 1.107–1.482, P < 0.001). IL-6 was predictive only in HCV patients (OR = 1.508, P < 0.001). TNF-α performed well (> 85%) in all groups. IFN-γ performed well in co-infection and COVID-19 (> 83%), but was moderately accurate in HCV (about 60%). IL-6 showed perfect accuracy in co-infection and COVID-19. Genotype analysis of the leptin gene polymorphism (rs7799039, G > A) indicated that the GA genotype was the most common across all study groups. The AA genotype of the leptin gene (rs7799039, G > A) was more frequent in individuals with COVID-19, suggesting a potential association with increased disease susceptibility. Conversely, the GG genotype was more commonly observed in the control group, which may indicate a protective role against infection. Statistical analysis revealed a significant relationship between genotype and disease status (χ² = 13.52, P = 0.035 < 0.05). This study highlights the distinct roles of IL-6, TNF-α, and IFN-γ in HCV, COVID-19, and co-infections, with more pronounced cytokine interactions in dual infections. Furthermore, the AA genotype may be associated with increased susceptibility to COVID-19, while the GG genotype was more frequent among controls, suggesting a possible protective trend that warrants further investigation. This study suggests differential roles of IL-6, TNF-α, and IFN-γ across HCV, COVID-19, and co-infections, with indications of more pronounced cytokine interactions in dual infections. Furthermore, the GA genotype appeared more common among patients, while the GG genotype was more frequent in controls, suggesting a possible protective trend. The AA genotype showed a slight increase in COVID-19 cases, but this association was not statistically significant and should be interpreted with caution.

The online version contains supplementary material available at 10.1038/s41598-026-35418-4.

## Full-text entities

- **Genes:** IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572] {aka CD130, CDW130, GP130, HIES4, HIES4A, HIES4B}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, STIL (STIL centriolar assembly protein) [NCBI Gene 6491] {aka MCPH7, SIL}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** hypercoagulability (MESH:D019851), critically ill (MESH:D016638), liver fibrosis (MESH:D008103), hepatocellular carcinoma (MESH:D006528), fibrosis (MESH:D005355), Chronic HCV infection (MESH:D019698), infectious disease (MESH:D003141), HBV infection (MESH:D006509), HIV-infected (MESH:D015658), pulmonary fibrosis (MESH:D011658), immune dysregulation (OMIM:614878), systemic (MESH:D015619), bacterial infection (MESH:D001424), thyroid dysfunction (MESH:D013959), liver dysfunction (MESH:D017093), HCV (MESH:D006526), co (MESH:D060085), tissue injury (MESH:D017695), -infected (MESH:D007239), schistosomiasis (MESH:D012552), pulmonary edema (MESH:D011654), obese (MESH:D009765), autoimmune disorders (MESH:D001327), acute and chronic inflammation (MESH:D007249), metabolic (MESH:D008659), lung inflammation (MESH:D011014), lung damage (MESH:D008171), long-term COVID-19 (MESH:D000094024), hepatic steatosis (MESH:D005234), adiposity (MESH:D018205), endothelial dysfunction (MESH:D014652), hepatic micro-thrombi (MESH:C536681), metabolic dysregulation (MESH:D021081), hepatic injury (MESH:D056486), acute respiratory syndrome (MESH:D012120), respiratory damage (MESH:D012140), dual infection (MESH:D009105), chronic liver disease (MESH:D008107), overweight (MESH:D050177), cardiovascular disease (MESH:D002318), death (MESH:D003643), organ damage (MESH:D000092124), COVID-19 (MESH:D000086382), SARS (MESH:D045169), viral diseases (MESH:D014777), chronic (MESH:D002908), insulin resistance (MESH:D007333), influenza (MESH:D007251), non-alcoholic fatty liver disease (MESH:D065626), metabolic syndrome (MESH:D024821), cytokine storm (MESH:D000080424), diabetes (MESH:D003920)
- **Chemicals:** DIF50 (-), glucose (MESH:D005947), sarilumab (MESH:C000592401), lipid (MESH:D008055), siltuximab (MESH:C504234), alcohol (MESH:D000438), O2 (MESH:D010100), tocilizumab (MESH:C502936), EDTA (MESH:D004492)
- **Species:** hepatitis C virus [taxon 11103], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Mutations:** AUC of 1, AUC of 0, G2548A, G > A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864950/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12864950/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864950/full.md

---
Source: https://tomesphere.com/paper/PMC12864950